Key result
Standard heart failure treatment improved left ventricular ejection fraction and reduced morphological features of left ventricular noncompaction in two adult patients, demonstrating phenotypic plasticity.
Why the study?
LVNC is a genetically and phenotypically heterogeneous condition that has been increasingly recognized, but phenotypic plasticity or undulation in response to treatment remains an important element to characterize.
Case Report (n=2)
No
This case report highlights the phenotypic plasticity of left ventricular noncompaction cardiomyopathy, demonstrating that morphological features can be reversible and improve alongside LV function with standard heart failure therapy.
Answers are grounded in this paper and cite their sources.
May support reversibility of LV noncompaction features with HF therapy in adults; hypothesis-generating and requires prospective confirmation.
Left ventricular noncompaction cardiomyopathy (LVNC) is a heart muscle disorder morphologically characterized by reticulated trabeculations and intertrabecular recesses in the left ventricular (LV) cavity. LVNC is a genetically and phenotypically heterogeneous condition, which has been increasingly recognized with the accumulation of evidence provided by genotype-phenotype correlation analyses. Here, we report 2 sporadic adult cases of LVNC; both developed acute heart failure as an initial clinical manifestation and harbored causal sarcomere gene mutations. One case was a 57-year-old male with digenic heterozygote mutations, p.R1344Q in myosin heavy chain 7 (MYH7) and p.R144W in troponin T2, cardiac type (TNNT2), who showed morphological characteristics of LVNC in the lateral to apical regions of the LV together with a comorbidity of non-transmural myocardial infarction, resulting from a coronary artery stenosis. After the removal of ischemic insult and standard heart failure treatment, LVNC became less clear, and LV function gradually improved. The other case was a 36-year-old male with a heterozygote mutation, p.E334K in myosin binding protein C3 (MYBPC3), who exhibited cardiogenic shock on admission with morphological characteristics of LVNC being most prominent in the apical segment of the LV. The dosage of beta-blocker was deliberately increased in an outpatient clinic over 6 months following hospitalization, which remarkably improved the LV ejection fraction from 21% to 54.3%. Via a combination of imaging and histopathological and genetic tests, we have found that these cases are not compatible with a persistent phenotype of primary cardiomyopathy, but their morphological features are changeable in response to treatment. Thus, we point out phenotypic plasticity or undulation as a noticeable element of LVNC in this case report.
No takes yet. Share an insight, caveat, or question.
Miyake et al. (2021) conducted a case report in Left Ventricular Noncompaction Cardiomyopathy (LVNC) (n=2). Standard heart failure treatment (beta-blockers, diuretics) and percutaneous coronary intervention was evaluated on Left ventricular ejection fraction and morphological changes. Standard heart failure treatment improved left ventricular ejection fraction and reduced morphological features of left ventricular noncompaction in two adult patients, demonstrating phenotypic plasticity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: